4 evolution "https:" "https:" "https:" "https:" "https:" "https:" "Helmholtz Zentrum Hereon" uni jobs at Center for Biologics Evaluation and Research (CBER)

FDA Non-clinical Identification and Mitigation of Safety Risks During the Development and Licensure of Protein-therapeutics

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 5 days ago

*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available in the Division of Plasma Protein Therapeutics (DPPT), Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration (FDA) in Silver Spring, Maryland. The...

FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 19 hours ago

Biol, 169718 (2026). https://doi.org:10.1016/j.jmb.2026.169718 Katneni, U.K., Liss, A., Holcomb, D., Katagiri, N., Hunt, R.C., Bar, H., Ismail, A., Komar, A.A. and Kimchi-Sarfaty, C.: Splicing

FDA Research Opportunity in Developing Methods for Efficient Gene Editing in Hematopoietic Stem Cells (HSCs)

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 20 hours ago

the regulation of biological and related products including blood, vaccines, allergenics, tissues, and cellular and gene therapies. Research Project: This research project focuses on advancing the development and

FDA Evaluation of Platelets: Antimicrobial Treatments and Evaluation of the Treated Products for Functions

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | about 20 hours ago

on the functions of the blood components such as platelets etc. Development of functional quality biomarkers for blood components such as platelets Learning Objectives: By the end of this training opportunity, you